Literature DB >> 19231990

Racial and ethnic variations in the incidence of cancers of the uterine corpus, United States, 2001-2003.

Susan A Sabatino1, Sherri L Stewart, Reda J Wilson.   

Abstract

OBJECTIVE: We examined racial/ethnic variations in uterine corpus cancer incidence.
METHODS: Data are from state cancer registries meeting quality criteria in the National Program of Cancer Registries (NPCR) and Surveillance, Epidemiology, and End Results (SEER) programs, 2001-2003. We included females with microscopically confirmed invasive uterine corpus cancer (n = 97,098). We calculated age-adjusted incidence rates per 100,000, stratified by race and ethnicity.
RESULTS: Cancers were most common among women who were 50-64 years old, white and non-Hispanic. Epithelial cancer rates were lower for Asian/Pacific Islanders (API) than whites (12.8 vs. 21.7, p < 0.0001), including serous adenocarcinoma (0.5 vs. 0.9, p < 0.0001). Epithelial cancer rates were also lower for American Indian/Alaska Natives (AIAN) vs. whites (11.5 vs. 21.7, p < 0.0001) and Hispanics vs. non-Hispanics (16.0 vs. 21.3, p < 0.0001). Among all race groups, blacks had the highest rates of mesenchymal (0.9) and mixed cancers (2.0) and of serous adenocarcinoma (2.0), clear cell adenocarcinoma (0.5), and carcinosarcoma (1.9). Blacks also had the lowest rates of low-grade and localized stage epithelial cancer and the highest rates of high-grade and distant stage disease.
CONCLUSIONS: Uterine corpus cancer rates are generally lower for API and AIAN than for whites or blacks and for Hispanics vs. non-Hispanics. Further research is needed to understand reasons for the differences in incidence.

Entities:  

Mesh:

Year:  2009        PMID: 19231990     DOI: 10.1089/jwh.2008.1171

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  5 in total

1.  Obesity and late-age survival without major disease or disability in older women.

Authors:  Eileen Rillamas-Sun; Andrea Z LaCroix; Molly E Waring; Candyce H Kroenke; Michael J LaMonte; Mara Z Vitolins; Rebecca Seguin; Christina L Bell; Margery Gass; Todd M Manini; Kamal H Masaki; Robert B Wallace
Journal:  JAMA Intern Med       Date:  2014-01       Impact factor: 21.873

2.  Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial.

Authors:  Louise A Brinton; Ashley S Felix; D Scott McMeekin; William T Creasman; Mark E Sherman; David Mutch; David E Cohn; Joan L Walker; Richard G Moore; Levi S Downs; Robert A Soslow; Richard Zaino
Journal:  Gynecol Oncol       Date:  2013-02-26       Impact factor: 5.482

3.  Cancer incidence trends among Asian American populations in the United States, 1990-2008.

Authors:  Scarlett Lin Gomez; Anne-Michelle Noone; Daphne Y Lichtensztajn; Steve Scoppa; James T Gibson; Lihua Liu; Cyllene Morris; Sandy Kwong; Kari Fish; Lynne R Wilkens; Marc T Goodman; Dennis Deapen; Barry A Miller
Journal:  J Natl Cancer Inst       Date:  2013-07-22       Impact factor: 13.506

4.  Gynecologic cancer incidence and mortality among American Indian/Alaska Native women in the Pacific Northwest, 1996-2016.

Authors:  Amanda S Bruegl; Sujata Joshi; Samantha Batman; Mercedes Weisenberger; Elizabeth Munro; Thomas Becker
Journal:  Gynecol Oncol       Date:  2020-04-15       Impact factor: 5.482

5.  Uterine clear cell carcinoma risk in White versus non-White US subpopulations: does race matter?

Authors:  Stephanie Chow; Deanna Wong; Cheng I Liao; Amandeep Mann; Chunqiao Tian; Kathleen M Darcy; John K Chan
Journal:  J Gynecol Oncol       Date:  2020-11       Impact factor: 4.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.